Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

107 trials with published results (35%)

Research Maturity

232 completed trials (76% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

5.2%

16 terminated out of 307 trials

Success Rate

93.5%

+7.0% vs benchmark

Late-Stage Pipeline

27%

82 trials in Phase 3/4

Results Transparency

46%

107 of 232 completed with results

Key Signals

107 with results94% success16 terminated

Data Visualizations

Phase Distribution

276Total
Not Applicable (92)
Early P 1 (3)
P 1 (24)
P 2 (75)
P 3 (36)
P 4 (46)

Trial Status

Completed232
Unknown23
Recruiting19
Terminated16
Withdrawn11
Not Yet Recruiting4

Trial Success Rate

93.5%

Benchmark: 86.5%

Based on 232 completed trials

Clinical Trials (307)

Showing 20 of 20 trials
NCT02108080RecruitingPrimary

Characterization Imaging Instruments in Alcoholics and Non-Alcoholics

NCT07388693Not ApplicableRecruitingPrimary

Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence

NCT04154111Not ApplicableCompleted

Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users

NCT07216872Not ApplicableRecruiting

Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)

NCT06308484Not ApplicableRecruitingPrimary

Neuromodulation and Mindfulness Patients With AUD

NCT02108054Not ApplicableRecruitingPrimary

Behavioral and Functional Task Development, Implementation, and Testing

NCT06770556Not ApplicableRecruiting

Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study

NCT02438969Completed

Epi-Genetic Modulators of Fear Extinction in Alcohol Dependence

NCT06684483Recruiting

The Impact of Heavy Alcohol Use on Saliva and Oral Health

NCT05747703Not ApplicableActive Not Recruiting

Telehealth Treatment for Alcohol Use Disorder

NCT06939088Phase 2Recruiting

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

NCT06333457CompletedPrimary

Presence and Relapse Rates in Patients With Alcohol Use Disorder Using Virtual Reality

NCT06405607Phase 2Recruiting

Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial

NCT01182766Phase 2CompletedPrimary

New Treatment for Alcohol and Nicotine Dependence

NCT04581499Not ApplicableCompleted

Tech-Enabled CM for AUD at Scale

NCT05738174Not ApplicableRecruitingPrimary

High-dose Accelerated Theta Burst Stimulation for the Treatment of Alcohol Addiction

NCT05620940Phase 1Recruiting

A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.

NCT07131124Not ApplicableNot Yet Recruiting

Can Selfcompassion Training Reduce Alcohol Consumption in Patients With Alcohol Use Disosrder ?

NCT01437046Early Phase 1CompletedPrimary

Doxazosin an a1 Antagonist for Alcohol Dependence

NCT03481049Not ApplicableCompleted

Individualizing Incentives for Alcohol in the Severely Mentally Ill

Scroll to load more

Research Network

Activity Timeline